Mikael Jumppanen

Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1

Otto Kauko, Susumu Y. Imanishi, Evgeny Kulesskiy et al. · Journal of Biological Chemistry · 2020 · 71 citations · Full text

Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling

Otto Kauko, Teemu D. Laajala, Mikael Jumppanen et al. · Scientific Reports · 2015 · 62 citations · Full text

PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells

Amanpreet Kaur, Oxana V. Denisova, Xi Qiao et al. · Cancer Research · 2016 · 49 citations

Neuro-oncology, Many Kinase Inhibitors, Chemoprevention Strategy +13

Optimized design and analysis of preclinical intervention studies in vivo

Teemu D. Laajala, Mikael Jumppanen, Riikka Huhtaniemi et al. · Scientific Reports · 2016 · 48 citations · Full text

Biosynthesis of the Bis-Prenylated Alkaloids Muscoride A and B

Antti Mattila, Rose-Marie Andsten, Mikael Jumppanen et al. · ACS Chemical Biology · 2019 · 47 citations · Full text